MOR-麻辣燙違禁品檢測(cè)試紙

   廣州健侖生物科技有限公司 

Urine based screening tests for drugs of abuse range from simple immunoassay tests to complex analytical procedures. The speed and sensitivity of immunoassays have made them the most widely accepted method for screening urine for drugs of abuse.

The DOA Panels are based on the principle of the highly specific immunochemical reactions of antigens and antibodies, which are used for the analysis of specific compounds in human urine. The DOA Screen Panels are rapid, visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of 11-nor-D⁹-tetrahydrocannabinol-9-carboxylic acid, Benzoylecgonine, Phencyclidine, Morphine, Methadone, Methamphetamine, Amphetamine, Barbiturates, Oxazepam, Nortriptyline, MDMA, ，Ketamine，Buprenorphine-3-D-Glucuronide, Tramadol and EDDP in urine. The length of time following drug use for which a positive result may occur is dependent upon several factors including the frequency and amount of drug, metabolic rate, excretion rate, drug half-life, and the drug user’s age, weight, activity and diet. 

MOR-麻辣燙違禁品檢測(cè)試紙

檢測(cè)原理

適用于 JIEDU所、醫(yī)院、*征兵、高危人群普查、特種行業(yè)和招工體檢工作中篩檢以及衛(wèi)生防疫部門對(duì)食品檢查等

目前違禁品檢測(cè)試劑主要是以金標(biāo)法（膠體金）檢測(cè)試劑進(jìn)行尿液檢測(cè)為主，主要特點(diǎn)是快速、方便、便于攜帶、準(zhǔn)確率高等特點(diǎn)。檢測(cè)試劑的檢測(cè)種類如下表：

【儲(chǔ)存條件及有效期】

1、儲(chǔ)存條件：原包裝于2～30℃陰涼干燥處保存，不得凍存，在有效期內(nèi)使用。

2、有效期：18個(gè)月                  

在中國進(jìn)行的研究中，從2011年到2014年，研究人員從4個(gè)省份的屠宰豬體內(nèi)以及廣州市30個(gè)露天市場(chǎng)和27個(gè)超市銷售的豬肉和雞肉中采集了細(xì)菌樣本。他們還對(duì)廣東和浙江兩家醫(yī)院的感染患者體內(nèi)細(xì)菌進(jìn)行了分析。
他們發(fā)現(xiàn)，從動(dòng)物和生肉中采集的大腸桿菌樣本內(nèi)存在mcr-1基因的比例很細(xì)菌。更令人擔(dān)憂的是，陽性樣本的比例逐年升細(xì)菌，而且在1322名住院患者的16份大腸桿菌和肺炎克雷伯菌樣本中也發(fā)現(xiàn)了mcr-1基因。
澳大利亞昆士蘭大學(xué)的戴維?佩特森和帕特里克?哈里斯在《柳葉刀?傳染細(xì)菌》雜志上發(fā)表評(píng)論文章說，粘菌素在農(nóng)業(yè)中的使用、屠宰動(dòng)物體內(nèi)的粘菌素耐藥性、食物中的粘菌素耐藥性、人體內(nèi)的粘菌素耐藥性之間的關(guān)系鏈現(xiàn)在已經(jīng)完整。使這些環(huán)節(jié)脫鉤的少數(shù)解決辦法之一是限制或停止粘菌素在農(nóng)業(yè)中的使用。否則就會(huì)引發(fā)大規(guī)模的公共衛(wèi)生問題?？股卦鞘澜缟蟴ui有效、革命性的藥物，但是由于細(xì)菌能夠快速進(jìn)化出抗生素耐藥性，因此抗生素似乎達(dá)到了其使用極限?？股啬退幮缘某霈F(xiàn)給世界各地的人們都造成了嚴(yán)重的威脅，自抗生素發(fā)現(xiàn)以來一度被認(rèn)為是輕而易舉可以治愈的疾細(xì)菌如今也再次成為人們的噩夢(mèng)。許多研究者至今仍在致力于尋找新的抗生素，但是這相當(dāng)于在為醫(yī)生與細(xì)菌之間的軍備競(jìng)賽火上澆油。
有調(diào)查表明，在美國醫(yī)院感染的細(xì)菌中，有一半細(xì)菌具抗生素耐藥性。根據(jù)美國疾細(xì)菌預(yù)防控制中心的報(bào)告，在美國，每年有將近200萬人受到耐藥菌感染，其中23000因此死亡。
一直以來，人們對(duì)于治療微生物感染的方案都集中在清除這些微生物上，然而真正具有致命性的并不是微生物本身，而是由感染引發(fā)的副效應(yīng)。研究證明，如果能夠阻止細(xì)菌原菌感染后引發(fā)的機(jī)體損傷，比如肌肉細(xì)菌（muscle wasting）癥狀，就能夠有效防止感染造成的致命性危害。
現(xiàn)在，科學(xué)家們也許找到了能夠解決這一難題的辦法——即一種寄生在腸道的、能夠遷移到其它器官組織的"超級(jí)英雄"細(xì)菌，這種細(xì)菌能夠緩解超級(jí)細(xì)菌感染帶來的致命的癥狀。發(fā)表在2015年10月30日的Science雜志上的一篇文章中，研究人員發(fā)現(xiàn)小鼠微生物組中的一株大腸桿菌能夠提細(xì)菌小鼠對(duì)肺部和腸道感染的耐受性，具體表現(xiàn)在一般小鼠在受到感染時(shí)會(huì)出現(xiàn)肌肉細(xì)菌，而這一株大腸桿菌能夠有效阻止肌肉細(xì)菌?？茖W(xué)家們將這株菌稱為“超級(jí)英雄”細(xì)菌。

獨(dú)立包裝：BZO-BAR-COC--THC -MET--OPI-OXY-MDMA-PCP- AMP-XTC-MTD 或聯(lián)檢

添加掃一掃二維碼：

【公司名稱】 廣州健侖生物科技有限公司

【市場(chǎng)部】       楊永漢
【】 
【騰訊 】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號(hào)二期2幢101-103室

企業(yè)文化

In a study conducted in China, from 2011 to 2014, researchers collected bacterial samples from pork and chicken sold in slaughter pigs in four provinces and in 30 open-air markets in Guangzhou and 27 supermarkets. They also analyzed bacteria in infected patients in Guangdong and Zhejiang hospitals.
They found that the proportion of mcr-1 gene present in E. coli samples collected from animals and raw meat was very high. Even more worrisome is the fact that the proportion of positive samples rises year by year, and the mcr-1 gene is also found in 16 samples of 1322 inpatients with E. coli and Klebsiella pneumoniae.
David Paterson and Patrick Harris of the University of Queensland in Australia commented in The Lancet Infectious Bacteria magazine that the use of colistin in agriculture and colistin resistance in slaughtered animals , The link between the colistin resistance in food and the colistin resistance in the human body is now complete. One of the few solutions to decoupling these links is to limit or stop the use of colistin in agriculture. Otherwise, it will lead to large-scale public health problems. Antibiotics was once the most effective and revolutionary drug in the world, but antibiotics seem to have reached their limits of use as bacteria rapidly evolve antibiotic resistance. The emergence of antibiotic resistance poses a serious threat to people all over the world, and bacteria once considered to be easy to cure since the discovery of antibiotics are now once again a nightmare. Many researchers are still working on finding new antibiotics so far, but this is tantamount to fueling the arms race between doctors and bacteria.
A survey shows that in the United States hospital-acquired bacteria, half of the bacteria with antibiotic resistance. According to a report by the U.S. Centers for Disease Control and Prevention, nearly 2 million people are infected with drug-resistant bacteria each year in the United States, of which 23,000 are dying.
All along, people are focused on the treatment of microbial infections of these microorganisms, but the real deadly is not the microorganisms themselves, but the side effects caused by the infection. Studies have shown that if you can prevent the bacterial damage caused by bacterial infections, such as muscle wasting symptoms, can effectively prevent the fatal hazards caused by infection.
Now scientists may find a solution to the problem - a "superhero" bacterium that is parasitic in the intestine and can migrate to other organs and tissues - a bacterium that mitigates the lethality caused by superbug infections Symptoms. In an article published in the October 30, 2015, Science magazine, the researchers found that one strain of E. coli in the mouse microbiome was able to raise the tolerance of bacterial mice to lung and intestinal infections, as demonstrated by Muscle bacteria develop when mice are infected in general and Escherichia coli can effectively prevent muscle bacteria. Scientists call this strain "superhero" bacteria.